Trial reportThe journal of nutrition, health & aging2009
Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience.
Trial report in The journal of nutrition, health & aging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Mitochondrial metabolism restoration via Tramiprosate suppresses mitochondrial ROS-driven foamy macrophage senescence post spinal cord injury.Journal of orthopaedic translation · 2026Article
- Implications of Microorganisms in Alzheimer's Disease.Current issues in molecular biology · 2022Review
- Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential.Marine drugs · 2021Review
- A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders.Frontiers in neurology · 2020Review
- The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017Review
- Network-based biomarkers in Alzheimer's disease: review and future directions.Frontiers in aging neuroscience · 2014Review
- Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).Expert opinion on emerging drugs · 2012Article
- Editorial: can we improve care for patients with dementia?The journal of nutrition, health & aging · 2011Article
- Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).Archives of medical science : AMS · 2011Article
- Quantitative structural MRI for early detection of Alzheimer's disease.Expert review of neurotherapeutics · 2010Review
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.Nature reviews. Drug discovery · 2010Review
- Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease.The journal of nutrition, health & aging · 2009Article
- Use of biomarkers in Alzheimer's trials.The journal of nutrition, health & aging · 2009Article
- Current treatment and recent clinical research in Alzheimer's disease.The Mount Sinai journal of medicine, New YorkReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.